
MindMaze Launches Dual Clinical Trials to Secure European Home-Care Funding
MindMaze Therapeutics has initiated clinical trials in Switzerland and France to validate its neurorehabilitation platform for home-based care. By enrolling patients in the SwissNeuroRehab and REACT-AVC studies, the Geneva-based firm aims to generate the clinical evidence required to secure public reimbursement for at-home stroke recovery across European markets.






















